1-13 of 13
thrombotic thrombocytopenic purpura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

Kadri Kangro, Elien Roose, Bérangère S. Joly, György Sinkovits, Tanja Falter, Charis von Auer, Heidi Rossmann, Marienn Reti, Jan Voorberg, Zoltán Prohászka, Bernhard Lämmle, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Andres Männik, Karen Vanhoorelbeke
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3427–3435.
https://doi.org/10.1182/bloodadvances.2020004172
Published: 2021
Includes: Supplemental data
Journal Articles

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Clinical Trials & Observations
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Hilde De Winter, Filip Callewaert
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2137–2141.
https://doi.org/10.1182/bloodadvances.2020001834
Published: 2021
Includes: Supplemental data
Journal Articles

Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura

George Goshua, Amit Gokhale, Jeanne E. Hendrickson, Christopher Tormey, Alfred Ian Lee
Journal: Blood Advances
Blood Adv (2020) 4 (3): 539–545.
https://doi.org/10.1182/bloodadvances.2019000827
Published: 2020
Includes: Supplemental data
Journal Articles

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Jingrui Sui, Wenjing Cao, Konstantine Halkidis, Mohammad S. Abdelgawwad, Nicole K. Kocher, Bryan Guillory, Lance A. Williams, Radhika Gangaraju, Marisa B. Marques, X. Long Zheng
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4177–4186.
https://doi.org/10.1182/bloodadvances.2019000939
Published: 2019
Includes: Supplemental data
Journal Articles

Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil

Clinical Trials & Observations
F. Fioredda, E. Cappelli, A. Mariani, A. Beccaria, E. Palmisani, A. Grossi, I. Ceccherini, R. Venè, C. Micalizzi, M. Calvillo, F. Pierri, I. Mancini, F. Peyvandi, F. Corsolini, C. Dufour, M. Miano
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3432–3435.
https://doi.org/10.1182/bloodadvances.2019000575
Published: 2019
Journal Articles

Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Lova Sun, Johnathan Mack, Ang Li, Justine Ryu, Vivek A. Upadhyay, Lynne Uhl, Richard M. Kaufman, Christopher P. Stowell, Walter S. Dzik, Robert S. Makar, Pavan K. Bendapudi
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1512–1518.
https://doi.org/10.1182/bloodadvances.2019031039
Published: 2019
Includes: Supplemental data
Journal Articles

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

Clinical Trials & Observations
James N. George
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1510–1516.
https://doi.org/10.1182/bloodadvances.2018018432
Published: 2018
Journal Articles

Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah’s Witness experience

Clinical Trials & Observations
James N. George, Steven A. Sandler, Joanna Stankiewicz
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2161–2165.
https://doi.org/10.1182/bloodadvances.2017012351
Published: 2017
Journal Articles

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2075–2082.
https://doi.org/10.1182/bloodadvances.2017009308
Published: 2017
Journal Articles

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Clinical Trials & Observations
John-Paul Westwood, Mari Thomas, Ferras Alwan, Vickie McDonald, Sylvia Benjamin, William A. Lester, Gillian C. Lowe, Tina Dutt, Quentin A. Hill, Marie Scully
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1159–1166.
https://doi.org/10.1182/bloodadvances.2017008268
Published: 2017
Journal Articles

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Clinical Trials & Observations
Evaren E. Page, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, James N. George
Journal: Blood Advances
Blood Adv (2017) 1 (10): 590–600.
https://doi.org/10.1182/bloodadvances.2017005124
Published: 2017
Journal Articles

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Clinical Trials & Observations
Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S. Kaplan, James D. McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V. Catalano, Sanjeev D. Chunilal, Anna Johnston, Stephen S. Opat, Jake Shortt
Journal: Blood Advances
Blood Adv (2016) 1 (1): 31–35.
https://doi.org/10.1182/bloodadvances.2016001412
Published: 2016
Journal Articles

Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura

Liang Zheng, Yingying Mao, Mohammad S. Abdelgawwad, Nicole K. Kocher, Mandy Li, Xiangrong Dai, Benjamin Li, X. Long Zheng
Journal: Blood Advances
Blood Adv (2016) 1 (1): 75–83.
https://doi.org/10.1182/bloodadvances.2016000711
Published: 2016
Includes: Multimedia, Supplemental data